CSPC Pharmaceutical Group Limited. Receivables

CSPC Pharmaceutical Group Limited. (CSPCY) currently reports a receivables of $11B as of December 2025. That compares with $9.9B in the prior-year period — up 7.0% year over year. Use the charts on this page to explore CSPC Pharmaceutical Group Limited.'s receivables history and peer comparisons.

CSPC Pharmaceutical Group Limited.'s receivables increased from $9.9B to $11B — a 7.0% year-over-year increase (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

CSPC Pharmaceutical Group Limited. reported $11B in receivables as of December 2025. That compares with $9.9B in the prior-year period — up 7.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $11B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for CSPC Pharmaceutical Group Limited., and consider following CSPCY for alerts when major investors trade the stock.

CSPC Pharmaceutical Group Limited. is classified in the Healthcare sector. On receivables, it currently shows $11B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CSPCY with unrelated industries.